dactinomycin has been researched along with Foot Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hicks, MJ; Reddy, K; Roy, A; Vasudevan, SA; Venkatramani, R; Whittle, SB | 1 |
Bhana, D; Kyalwazi, SK; Master, SP | 1 |
Stehlin, JS | 1 |
1 review(s) available for dactinomycin and Foot Diseases
Article | Year |
---|---|
Congenital spindle cell rhabdomyosarcoma.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Extremities; Female; Foot Diseases; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Nuclear Receptor Coactivator 2; Oncogene Proteins, Fusion; Remission Induction; Rhabdomyosarcoma, Embryonal; Soft Tissue Neoplasms; TEA Domain Transcription Factors; Thigh; Thoracic Neoplasms; Thoracic Wall; Vincristine | 2019 |
2 other study(ies) available for dactinomycin and Foot Diseases
Article | Year |
---|---|
Actinomycin D in malignant Kaposi's sarcoma.
Topics: Adult; Aged; Bone Neoplasms; Dactinomycin; Drug Eruptions; Female; Foot Diseases; Hand; Humans; Lymph Nodes; Male; Middle Aged; Nausea; Sarcoma, Kaposi; Skin Neoplasms; Stomatitis; Thigh; Triaziquone; Vomiting | 1971 |
Hyperthermic perfusion with chemotherapy for cancers of the extremities.
Topics: Arm; Burns; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Edema; Femoral Neoplasms; Foot Diseases; Hemangiosarcoma; Hemoglobinuria; Hemolysis; Hot Temperature; Humans; Leg; Melanoma; Melphalan; Neoplasm Metastasis; Sarcoma; Sarcoma, Ewing; Sarcoma, Kaposi; Time Factors | 1969 |